Skip to main content
Trigyn Announces AI Innovation and Delivery Center

Trigyn Announces AI Innovation and Delivery Center

Trigyn announces AI innovation and delivery center

Mumbai. Trigyn Technologies Ltd. is pleased to announce plans to establish and AI innovation and delivery center in the City of Hyderabad, in the State of Telangana, India. Trigyn expects the centre to grow to achieve a total of 1,000 workers over three years. Based on the progress of AI proof of concept and pilot projects with clients, Trigyn anticipates moving forward with this initiative in the next six months.

For more than 35 years, and spanning more than 28 countries, Trigyn has grown to become the trusted technology partner of governments, international governmental organizations, public sector entities, and private corporations. Trigyn is ISO 9001:2015, ISO 27001:2013 (ISMS), ISO 20000:2018, and CMMI DEV Level 5 certified.

Recent News

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Launch of e-Migrate Portal and App will Streamline Overseas Employment

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded Baltimore County, Maryland Temporary Staffing Contract

Trigyn Awarded – State of Louisiana – IT Staffing Contract

Trigyn Awarded – State of Louisiana – IT Staffing Contract

Trigyn Awarded – State of Louisiana – IT Staffing Contract

Trigyn Technologies Inc. is a wholly owned subsidiary of Trigyn Technologies Ltd. collectively, we are committed to providing transparent and timely information to all of the stakeholders who have put their trust in us.

For any media-related inquiries, we encourage you to use our “Contact Us” form, available by clicking here.

For information about investment-related topics or stock information, please visit our Investors page by clicking here. For Investor or stock related inquiries, please use the contact information specified on the Investors page.

Thank you for your interest in Trigyn.